Counterpart to Registration Rights Agreement December 22, 2014
EX-10.210 6 ex10210rracounterpart53752.htm RRA 5.375% 2023 DEC 22 Ex. 10.210 RRA Counterpart 5.375% 2023
Exhibit 10.210
Counterpart to Registration Rights Agreement
December 22, 2014
Each of the undersigned hereby absolutely, unconditionally and irrevocably agrees as a Guarantor, as defined in the Registration Rights Agreement, dated June 30, 2014 by and among Endo Finance LLC, a Delaware limited liability company and Endo Finco Inc., a Delaware corporation, the Guarantors party thereto, Citigroup Global Markets Inc. and RBC Capital Markets, relating to the 5.375% Senior Notes due 2023, to be bound by the terms and provisions of such Registration Rights Agreement.
1
Exhibit 10.210
IN WITNESS WHEREOF, each of the undersigned has executed this counterpart as of the date first written above.
BOCA PHARMACAL, LLC, as a | |
by GENERICS INTERNATIONAL (US), INC., its | |
sole member |
By: | /s/ Deanna Voss |
Name: Deanna Voss | |
Title: Assistant Secretary |
DAVA INTERNATIONAL, LLC, as a | |
by DAVA PHARMACEUTICALS, INC., its | |
sole member |
By: | /s/ Deanna Voss |
Name: Deanna Voss | |
Title: Assistant Secretary |
DAVA CAPITAL MANAGEMENT, INC., as a |
By: | /s/ Deanna Voss |
Name: Deanna Voss | |
Title: Assistant Secretary |
2